Unlocking the true power of CRISPR for molecular detection.

A single engineered RNP specifically detects the nucleic-acid target and drives directed signal amplification, producing analytical reaction times in mere minutes.

Unlike PCR or other amplification technologies, VedaBio's platform enables high-performance, highly scalable and rapid assays, pooling multiple targets within a single reaction, like a molecular switch, for massive multiplexing, all without target amplification.

The combined use of engineered CRISPR enzymes, blocked sequences, and reporter molecules generates a robust signal without target amplification. Eliminating amplification removes the speed, cost and complexity bottlenecks that have kept molecular testing locked in the central lab.

With a generally applicable signal amplification, rapid product development is achieved through simple, AI-based target-sequence selection and optimization.